We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 104 results
  1. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies

    Purpose

    Somatic mutations on H3 histone are currently considered a genetic hallmark for midline pediatric high-grade gliomas (HGGs). Yet, different...

    Vinicius Fernandes Oliveira, Graziella Ribeiro De Sousa, ... Elvis Terci Valera in Child's Nervous System
    Article 07 August 2020
  2. H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series

    Background

    Diffuse hemispheric glioma, H3 G34-mutant, is a novel paediatric tumour type in the fifth edition of the WHO classification of CNS tumours...

    José Pedro Lavrador, Zita Reisz, ... Safa Al-Saraj in Acta Neurochirurgica
    Article 16 March 2023
  3. Epigenetics to clinicopathological features: a bibliometric analysis of H3 G34-mutant diffuse hemispheric glioma literature

    Purpose

    Pediatric-type diffuse high-grade gliomas are the leading cause of cancer-related morbidity and mortality in children. More than 30% of...

    Jordan T. Roach, Cecile Riviere-Cazaux, ... David J. Daniels in Child's Nervous System
    Article 13 April 2024
  4. Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review

    Introduction

    Diffuse hemispheric glioma, H3 G34-mutant (DHGs), is a newly categorized tumor in pediatric-type diffuse high-grade gliomas, World Health...

    Yasuhito Kegoya, Yoshihiro Otani, ... Isao Date in Journal of Neuro-Oncology
    Article Open access 01 March 2024
  5. Genetic and other epidemiological risk factors of infants and children with hypospadias: a case control study

    Background

    To study hypospadias as regard epidemiological risk factors and genetic association with mutations in Steroid 5 alpha reductase type 2...

    Wafaa Moustafa, Soheir Abouelella, ... Fouad Zanaty in African Journal of Urology
    Article Open access 16 October 2023
  6. Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review

    Background

    Advances in molecular diagnostics accomplished the discovery of two malignant glioma entities harboring alterations in the H3 histone:...

    Arian Lasocki, Gehad Abdalla, ... Stefanie C. Thust in Cancer Imaging
    Article Open access 17 November 2022
  7. The epigenetic dysfunction underlying malignant glioma pathogenesis

    Comprehensive molecular profiling has dramatically transformed the diagnostic neuropathology of brain tumors. Diffuse gliomas, the most common and...

    Sharvari Dharmaiah, Jason T. Huse in Laboratory Investigation
    Article 12 February 2022
  8. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4

    Malignant brain tumors, known as H3K27-altered diffuse midline glioma (DMG) and H3G34-mutant diffuse hemispheric glioma (DHG), can affect individuals...

    Erik A. Williams, Priscilla K. Brastianos, ... Tareq A. Juratli in Acta Neuropathologica
    Article Open access 31 July 2023
  9. Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma

    Histone H3 mutations at amino acids 27 (H3K27M) and 34 (H3G34R) are recurrent drivers of pediatric-type high-grade glioma (pHGG). H3K27M mutations...

    Robert Siddaway, Laura Canty, ... Cynthia Hawkins in Acta Neuropathologica
    Article Open access 07 September 2022
  10. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact

    Purpose

    Gliomas represent the most frequent central nervous system (CNS) tumors in children and adolescents. However, therapeutic strategies for these...

    Débora Cabral de Carvalho Corrêa, Francine Tesser-Gamba, ... Silvia Regina Caminada de Toledo in Journal of Cancer Research and Clinical Oncology
    Article 09 October 2021
  11. Spinale Raumforderung – Astrozytom vs. diffuses Mittelliniengliom

    Due to the new WHO Classification 2021, primary brain tumors are classified based not only on histology but also on molecular genetic testing. We...

    Ines Spazierer in psychopraxis. neuropraxis
    Article 03 January 2024
  12. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021

    Purpose of Review

    The upcoming 2021 World Health Organization (WHO) Classification of Tumours of the Central Nervous System will feature numerous...

    Alejandro Perez, Jason T. Huse in Current Neurology and Neuroscience Reports
    Article 24 November 2021
  13. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors

    Molecular profiling has transformed the diagnostic workflow of CNS tumors during the last years. The latest WHO classification of CNS tumors (5th...

    Luca Bertero, Luca Mangherini, ... Felix Sahm in Virchows Archiv
    Article Open access 02 September 2023
  14. Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma

    Purpose

    The maintenance of telomere length prevents cancer cell senescence and occurs via two mutually exclusive mechanisms: (a) reactivation of...

    Simone Minasi, Caterina Baldi, ... Francesca Romana Buttarelli in Child's Nervous System
    Article Open access 31 October 2020
  15. Diffuse intrinsic pontine gliomas in pediatric patients: management updates

    Background

    This review explores how diffuse intrinsic pontine glioma (DIPG) diagnosis and treatment have evolved and are improving.

    Main body ...
    Caroline Davidson, Samuel Woodford, ... Brandon Lucke-Wold in Egyptian Journal of Neurosurgery
    Article Open access 14 November 2023
  16. Assessment of Ki-67 expression levels in IDH-wildtype glioblastoma using logistic regression modelling of VASARI features

    To investigate the value of using VASARI signs preoperatively to assess Ki-67 proliferation index levels in patients with IDH-wildtype glioblastoma...

    Liangcai Bai, Jian Jiang, Junlin Zhou in Neurosurgical Review
    Article 22 December 2023
  17. H3 G34-mutant high-grade glioma

    H3F3A G34 ( H3.3 G34)-mutant high-grade gliomas (HGG) are rare, and newly recognized infiltrating gliomas of the cerebral hemisphere. Here, we report...

    Ka Young Lim, Jae Kyung Won, ... Sung-Hye Park in Brain Tumor Pathology
    Article 29 September 2020
Did you find what you were looking for? Share feedback.